Results 11 to 20 of about 1,217,759 (290)
Hepatitis B and the Need for a Booster Dose [PDF]
Clinical Infectious Diseases, 2011 After several decades of vaccination against hepatitis B virus in newborns, infants, adolescents, and adults, the question remains whether a booster dose is ever needed. Long-term protection is most commonly measured through 4 methods: the anamnestic response after administration of a booster dose, infection rate in vaccinated populations, in vitro B ...
Leuridan, Elke, van Damme, Pierre
openaire +4 more sources
Uptake of COVID-19 Booster Dose among Saudi Arabian Population
Medicina, 2022 Backgroundand objectives: Although several vaccines have been produced and administered around the world, new SARS-CoV-2 worsened the COVID-19 infection risk and impacted the initial vaccine dosage effectiveness.
Najim Z. Alshahrani +7 more
doaj +2 more sources
COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis
Tropical Medicine and Infectious Disease, 2022 The World Health Organization (WHO) recommended coronavirus disease 2019 (COVID-19) booster dose vaccination after completing the primary vaccination series for individuals ≥18 years and most-at-risk populations.
Shaimaa Abdelaziz Abdelmoneim +12 more
doaj +2 more sources
Is There Any Opportunity to Provide an HBV Vaccine Booster Dose before Anti-Hbs Titer Vanishes?
Vaccines, 2020 Whether the primary Hepatitis B vaccination confers lifelong protection is debated. The aim of the study was to assess the effectiveness of booster doses in mounting a protective HBV immune response in subjects vaccinated 18–20 years earlier.
Rosa Papadopoli +4 more
doaj +3 more sources
Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy
Frontiers in Public Health, 2022 BackgroundThe coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is evolving,the newly emerged Omicron variant being the dominant strain worldwide, and this has raised concerns about ...
Giorgia Della Polla +9 more
doaj +2 more sources
Frontiers in Public Health, 2022 ObjectivesThis study was conducted to evaluate COVID-19 vaccine booster dose willingness and identify predictors and factors of willingness and hesitance in the vaccinated population of Pakistan.MethodsA cross-sectional web-based survey was undertaken ...
Abdul Moeed +7 more
doaj +1 more source
Antibody Response to COVID-19 Booster Vaccination in Healthcare Workers
Frontiers in Immunology, 2022 ObjectiveTo evaluate the mean increase of anti-S IgG antibody titer between the basal, pre-booster level to the titer assessed 14 days after the booster dose of BNT162b2.Patients and MethodsThe RENAISSANCE study is an observational, longitudinal ...
Arianna Pani +26 more
doaj +1 more source
Vaccines, 2023 Accurate studies on the dynamics of Pfizer-Biontech BNT162b2-induced antibodies are crucial to better tailor booster dose administration depending on age, comorbidities, and previous natural infection with SARS-CoV-2.
Laura V. Renna +15 more
doaj +1 more source
mBio, 2022 CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization (WHO). Previous studies reported increased levels of neutralizing antibodies and specific T cells 2 and 4 weeks after two doses of CoronaVac; these levels were ...
Bárbara M. Schultz +37 more
doaj +1 more source
Journal of Pharmaceutical Policy and Practice, 2023 Background COVID-19 booster dose vaccination acceptance and actual vaccination behavior is not known among Egyptian individuals with autoimmune and rheumatic diseases (ARDs).
Samar Tharwat +4 more
doaj +1 more source